Wen-Hsuan Wendy Lin, MD, PhD, joined Duke Pathology on Jan. 1, 2025, as an assistant professor and physician-scientist in the Division of Hematopathology. She earned her MD from National Cheng Kung University in Taiwan and her PhD from Johns Hopkins University in Baltimore, Maryland, where she studied immunity to viral infection and vaccination. She completed postdoctoral training in Immunology at Columbia University, focusing on the effects of metabolism on signaling pathways during T-cell differentiation.
Her research focuses on elucidating the tumor microenvironment ecosystem and the molecular mechanisms of transformation in peripheral T-cell lymphomas, an uncommon group of aggressive non-Hodgkin lymphomas that originate in T lymphocytes (a type of white blood cell). Lin aims to use her expertise in lymphoma biology, immunology, and pathology to establish a multidisciplinary research program. She hopes to translate her lab’s findings into advances in precision lymphoma diagnosis and treatment.
Lin pursued her residency in anatomic pathology and a fellowship in hematopathology at New York-Presbyterian Hospital/Columbia University Irving Medical Center, where she also served as chief resident in Pathology. During her residency, she completed a National Cancer Institute (NCI)-funded R38 physician-scientist training program under the mentorship of Teresa Palomero, PhD, and Adolfo Ferrando, MD, PhD. In 2022, Lin joined the Department of Pathology and Cell Biology at Columbia University as an instructor and an attending pathologist in the Division of Hematopathology.
In support of her work, she received an American Society of Clinical Oncology (ASCO) Young Investigator Award, a Columbia University Herbert Irving Comprehensive Cancer Center (HICCC) Early Career Development Pilot Award, and a Career Development Award from the Department of Defense.
In her free time, she enjoys spending time with her two children, visiting art museums, swimming, and exploring new recipes.